Liebesinsel

1. Johnson & Johnson – $56.1bn
2. Pfizer – $51.75bn
3. Roche – $49.23bn
4. Novartis – $47.45bn
5. Merck & Co. – $46.84bn
6. GlaxoSmithKline – $44.27bn
7. Sanofi – $40.46bn
8. AbbVie – $33.26bn
9. Takeda – $30.52bn
10. Shanghai Pharmaceuticals Holding – $26.69bn